Edition:
United Kingdom

Charles River Laboratories International Inc (CRL.N)

CRL.N on New York Stock Exchange

130.88USD
16 Nov 2018
Change (% chg)

$0.30 (+0.23%)
Prev Close
$130.58
Open
$130.00
Day's High
$132.79
Day's Low
$129.10
Volume
69,218
Avg. Vol
93,785
52-wk High
$138.69
52-wk Low
$96.70

Chart for

About

Charles River Laboratories International, Inc. is an early-stage contract research company. The Company is engaged in laboratory animal medicine and science (research model technologies) and develop a portfolio of discovery and safety assessment services, both good laboratory practice (GLP) and non-GLP, which supports its... (more)

Overall

Beta: 0.93
Market Cap(Mil.): $5,230.56
Shares Outstanding(Mil.): 47.59
Dividend: --
Yield (%): --

Financials

  CRL.N Industry Sector
P/E (TTM): 29.01 83.63 33.59
EPS (TTM): 3.79 -- --
ROI: 7.94 -0.64 15.05
ROE: 20.38 0.08 16.62

Cancer center CEO leaves Merck board after disclosure scandal

NEW YORK The chief executive of Memorial Sloan Kettering Cancer Center, Craig Thompson, resigned from the boards of drugmaker Merck & Co Inc and lab services firm Charles River Laboratories International Inc on Tuesday, following media investigations about the U.S. center's ties to the pharmaceutical industry.

02 Oct 2018

UPDATE 1-Cancer center CEO leaves Merck board after disclosure scandal

NEW YORK, Oct 2 The chief executive of Memorial Sloan Kettering Cancer Center, Craig Thompson, resigned from the boards of drugmaker Merck & Co Inc and lab services firm Charles River Laboratories International Inc on Tuesday, following media investigations about the U.S. center's ties to the pharmaceutical industry.

02 Oct 2018

Earnings vs. Estimates